Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	nuclear glucocorticoid receptor binding	NCOA2 NCOA6 EP300	7.09e-06	20	38	3	GO:0035259
GeneOntologyMolecularFunction	cyclosporin A binding	RANBP2 CWC27 PPIF	1.25e-05	24	38	3	GO:0016018
GeneOntologyMolecularFunction	phosphodiesterase I activity	ENPP1 ENPP2	3.51e-05	5	38	2	GO:0004528
GeneOntologyMolecularFunction	calcium ion binding	PCDHB8 PAM CUBN PNLIPRP1 ENPP1 ENPP2 CDHR1 PCDH19	6.80e-05	749	38	8	GO:0005509
GeneOntologyMolecularFunction	peptidyl-prolyl cis-trans isomerase activity	RANBP2 CWC27 PPIF	1.17e-04	50	38	3	GO:0003755
GeneOntologyMolecularFunction	dinucleotide phosphatase activity	ENPP1 ENPP2	1.26e-04	9	38	2	GO:0004551
GeneOntologyMolecularFunction	cis-trans isomerase activity	RANBP2 CWC27 PPIF	1.39e-04	53	38	3	GO:0016859
GeneOntologyMolecularFunction	nuclear estrogen receptor binding	NCOA2 NCOA6 STRN	1.39e-04	53	38	3	GO:0030331
GeneOntologyMolecularFunction	transforming growth factor beta receptor activity	TGFBR3 BMPR2	2.71e-04	13	38	2	GO:0005024
GeneOntologyMolecularFunction	nuclear receptor binding	NCOA2 NCOA6 STRN EP300	4.29e-04	187	38	4	GO:0016922
GeneOntologyMolecularFunction	adenylate cyclase activity	GUCY2F ADCY2	5.29e-04	18	38	2	GO:0004016
GeneOntologyMolecularFunction	cargo receptor activity	CUBN ENPP1 ENPP2	5.64e-04	85	38	3	GO:0038024
GeneOntologyMolecularFunction	transmembrane receptor protein serine/threonine kinase activity	TGFBR3 BMPR2	6.56e-04	20	38	2	GO:0004675
GeneOntologyMolecularFunction	peroxisome proliferator activated receptor binding	NCOA6 EP300	7.24e-04	21	38	2	GO:0042975
GeneOntologyMolecularFunction	BMP binding	TGFBR3 BMPR2	7.95e-04	22	38	2	GO:0036122
GeneOntologyMolecularFunction	phosphoric diester hydrolase activity	ENPP7 ENPP1 ENPP2	8.29e-04	97	38	3	GO:0008081
GeneOntologyMolecularFunction	nuclear retinoid X receptor binding	NCOA2 NCOA6	8.70e-04	23	38	2	GO:0046965
GeneOntologyMolecularFunction	cyclase activity	GUCY2F ADCY2	9.48e-04	24	38	2	GO:0009975
GeneOntologyMolecularFunction	phosphorus-oxygen lyase activity	GUCY2F ADCY2	1.03e-03	25	38	2	GO:0016849
GeneOntologyMolecularFunction	scavenger receptor activity	ENPP1 ENPP2	1.20e-03	27	38	2	GO:0005044
GeneOntologyMolecularFunction	polysaccharide binding	ENPP1 ENPP2	1.58e-03	31	38	2	GO:0030247
GeneOntologyMolecularFunction	nuclear thyroid hormone receptor binding	NCOA2 NCOA6	1.90e-03	34	38	2	GO:0046966
GeneOntologyMolecularFunction	lipase activity	ENPP7 PNLIPRP1 ENPP2	2.28e-03	138	38	3	GO:0016298
GeneOntologyMolecularFunction	transcription coactivator activity	NCOA2 NCOA6 EP300 SS18L1	2.56e-03	303	38	4	GO:0003713
GeneOntologyMolecularFunction	transcription factor binding	NCOA2 NCOA6 STRN NFAT5 EP300 ATXN3	2.78e-03	753	38	6	GO:0008134
GeneOntologyMolecularFunction	small GTPase binding	DOCK5 RANBP2 SGSM1 GARRE1	3.15e-03	321	38	4	GO:0031267
GeneOntologyMolecularFunction	GTPase binding	DOCK5 RANBP2 SGSM1 GARRE1	4.73e-03	360	38	4	GO:0051020
GeneOntologyMolecularFunction	nuclear retinoic acid receptor binding	NCOA2 NCOA6	4.91e-03	55	38	2	GO:0042974
GeneOntologyMolecularFunction	protein kinase A binding	PJA2 NBEA	5.45e-03	58	38	2	GO:0051018
GeneOntologyMolecularFunction	cysteine-type peptidase activity	GGH ALG13 ATXN3	5.77e-03	192	38	3	GO:0008234
GeneOntologyMolecularFunction	isomerase activity	RANBP2 CWC27 PPIF	5.77e-03	192	38	3	GO:0016853
GeneOntologyMolecularFunction	nuclear receptor coactivator activity	NCOA2 NCOA6	6.01e-03	61	38	2	GO:0030374
GeneOntologyMolecularFunction	lyase activity	PAM GUCY2F ADCY2	7.57e-03	212	38	3	GO:0016829
GeneOntologyMolecularFunction	RNA polymerase II-specific DNA-binding transcription factor binding	NCOA2 NCOA6 STRN EP300	7.90e-03	417	38	4	GO:0061629
GeneOntologyMolecularFunction	transmembrane receptor protein kinase activity	TGFBR3 BMPR2	1.14e-02	85	38	2	GO:0019199
GeneOntologyMolecularFunction	SMAD binding	TGFBR3 EP300	1.17e-02	86	38	2	GO:0046332
GeneOntologyBiologicalProcess	protein peptidyl-prolyl isomerization	RANBP2 CWC27 PPIF	5.04e-05	38	39	3	GO:0000413
GeneOntologyBiologicalProcess	cell morphogenesis	BMPR2 KANK1 WDR36 ENPP1 ENPP2 EP300 CDHR1 CNMD SS18L1 ADGRB1	5.53e-05	1194	39	10	GO:0000902
GeneOntologyBiologicalProcess	peptidyl-proline modification	RANBP2 CWC27 PPIF	1.45e-04	54	39	3	GO:0018208
GeneOntologyBiologicalProcess	epithelial cell migration	DOCK5 TGFBR3 BMPR2 KANK1 ENPP2 ADGRB1	1.48e-04	432	39	6	GO:0010631
GeneOntologyBiologicalProcess	epithelium migration	DOCK5 TGFBR3 BMPR2 KANK1 ENPP2 ADGRB1	1.54e-04	435	39	6	GO:0090132
GeneOntologyBiologicalProcess	tissue migration	DOCK5 TGFBR3 BMPR2 KANK1 ENPP2 ADGRB1	1.66e-04	441	39	6	GO:0090130
GeneOntologyBiologicalProcess	regulation of lamellipodium morphogenesis	KANK1 ENPP2	1.90e-04	11	39	2	GO:2000392
MousePheno	abnormal epicardium morphology	TGFBR3 NCOA6 EP300	1.04e-05	17	36	3	MP:0003057
MousePheno	abnormal myocardium compact layer morphology	NCOA6 BMPR2 NFAT5 EP300	2.53e-05	67	36	4	MP:0004056
MousePheno	abnormal vitelline vasculature morphology	PAM NCOA6 BMPR2 CUBN ENPP2 EP300	2.70e-05	235	36	6	MP:0003229
MousePheno	abnormal umbilical cord morphology	NCOA2 PAM NBEA	2.21e-04	46	36	3	MP:0001725
MousePheno	abnormal fetal cardiomyocyte proliferation	TGFBR3 NCOA6 NFAT5	2.51e-04	48	36	3	MP:0003567
MousePheno	abnormal vasculogenesis	TGFBR3 ENPP2 EP300	3.55e-04	54	36	3	MP:0001622
MousePheno	abnormal fetal cardiomyocyte physiology	TGFBR3 NCOA6 NFAT5	3.75e-04	55	36	3	MP:0011390
MousePheno	abnormal extraembryonic tissue morphology	NCOA2 TGFBR3 PAM NCOA6 NBEA BMPR2 CUBN ENPP2 EP300	3.78e-04	908	36	9	MP:0002086
MousePheno	failure of initiation of embryo turning	CUBN ENPP2 ALG13	3.96e-04	56	36	3	MP:0004180
MousePheno	abnormal vascular development	TGFBR3 PAM NCOA6 BMPR2 CUBN ENPP2 EP300	3.97e-04	542	36	7	MP:0000259
Domain	E-NPP	ENPP7 ENPP1 ENPP2	2.93e-07	7	39	3	IPR024873
Domain	Phosphodiest	ENPP7 ENPP1 ENPP2	1.00e-06	10	39	3	PF01663
Domain	Phosphodiest/P_Trfase	ENPP7 ENPP1 ENPP2	1.00e-06	10	39	3	IPR002591
Domain	Cyclophilin-type_PPIase_CS	RANBP2 CWC27 PPIF	7.97e-06	19	39	3	IPR020892
Domain	Cyclophilin-like_dom	RANBP2 CWC27 PPIF	1.26e-05	22	39	3	IPR029000
Domain	CSA_PPIASE_2	RANBP2 CWC27 PPIF	1.26e-05	22	39	3	PS50072
Domain	Pro_isomerase	RANBP2 CWC27 PPIF	1.26e-05	22	39	3	PF00160
Domain	-	RANBP2 CWC27 PPIF	1.26e-05	22	39	3	2.40.100.10
Domain	Cyclophilin-type_PPIase_dom	RANBP2 CWC27 PPIF	1.26e-05	22	39	3	IPR002130
Domain	CSA_PPIASE_1	RANBP2 CWC27 PPIF	1.26e-05	22	39	3	PS00170
Domain	Alkaline_phosphatase_core	ENPP7 ENPP1 ENPP2	3.63e-05	31	39	3	IPR017850
Domain	Alkaline_Pase-like_a/b/a	ENPP7 ENPP1 ENPP2	3.63e-05	31	39	3	IPR017849
Domain	-	ENPP7 ENPP1 ENPP2	3.63e-05	31	39	3	3.40.720.10
Domain	Somatomedin_B_chordata	ENPP1 ENPP2	4.23e-05	5	39	2	IPR020436
Domain	NUC	ENPP1 ENPP2	6.34e-05	6	39	2	SM00477
Domain	Nuc_rcpt_coact	NCOA2 EP300	6.34e-05	6	39	2	IPR009110
Domain	Endonuclease_NS	ENPP1 ENPP2	6.34e-05	6	39	2	SM00892
Domain	DNA/RNA_non-sp_Endonuclease	ENPP1 ENPP2	6.34e-05	6	39	2	IPR001604
Domain	-	ENPP1 ENPP2	6.34e-05	6	39	2	3.40.570.10
Domain	Endonuclease_NS	ENPP1 ENPP2	6.34e-05	6	39	2	PF01223
Domain	Extracellular_endonuc_su_A	ENPP1 ENPP2	6.34e-05	6	39	2	IPR020821
Domain	Somatomedin_B	ENPP1 ENPP2	1.18e-04	8	39	2	PF01033
Domain	SO	ENPP1 ENPP2	1.52e-04	9	39	2	SM00201
Domain	Somatomedin_B_dom	ENPP1 ENPP2	1.89e-04	10	39	2	IPR001212
Domain	SMB_1	ENPP1 ENPP2	1.89e-04	10	39	2	PS00524
Domain	SMB_2	ENPP1 ENPP2	1.89e-04	10	39	2	PS50958
Domain	A/G_cyclase_CS	GUCY2F ADCY2	5.66e-04	17	39	2	IPR018297
Domain	Nucleotide_cyclase	GUCY2F ADCY2	6.36e-04	18	39	2	IPR029787
Domain	-	GUCY2F ADCY2	6.36e-04	18	39	2	3.30.70.1230
Domain	GUANYLATE_CYCLASE_1	GUCY2F ADCY2	7.10e-04	19	39	2	PS00452
Domain	Guanylate_cyc	GUCY2F ADCY2	7.10e-04	19	39	2	PF00211
Domain	GUANYLATE_CYCLASE_2	GUCY2F ADCY2	7.10e-04	19	39	2	PS50125
Domain	A/G_cyclase	GUCY2F ADCY2	7.10e-04	19	39	2	IPR001054
Domain	CYCc	GUCY2F ADCY2	7.10e-04	19	39	2	SM00044
Domain	Cyclophilin-type_PPIase	CWC27 PPIF	8.70e-04	21	39	2	IPR024936
Domain	Cadherin_CS	PCDHB8 CDHR1 PCDH19	1.52e-03	109	39	3	IPR020894
Domain	CADHERIN_1	PCDHB8 CDHR1 PCDH19	1.68e-03	113	39	3	PS00232
Domain	Cadherin	PCDHB8 CDHR1 PCDH19	1.68e-03	113	39	3	PF00028
Domain	CADHERIN_2	PCDHB8 CDHR1 PCDH19	1.72e-03	114	39	3	PS50268
Domain	-	PCDHB8 CDHR1 PCDH19	1.72e-03	114	39	3	2.60.40.60
Domain	CA	PCDHB8 CDHR1 PCDH19	1.77e-03	115	39	3	SM00112
Domain	Cadherin-like	PCDHB8 CDHR1 PCDH19	1.81e-03	116	39	3	IPR015919
Domain	Cadherin	PCDHB8 CDHR1 PCDH19	1.90e-03	118	39	3	IPR002126
Domain	Quinoprotein_ADH-like_supfam	WDR36 PCDH19	5.47e-03	53	39	2	IPR011047
Pathway	REACTOME_RORA_ACTIVATES_GENE_EXPRESSION	NCOA2 CHD9 NCOA6 EP300	9.50e-08	18	35	4	M26942
Pathway	REACTOME_HEME_SIGNALING	NCOA2 CHD9 NCOA6 EP300	6.23e-06	49	35	4	M41832
Pathway	REACTOME_CIRCADIAN_CLOCK	NCOA2 CHD9 NCOA6 EP300	2.60e-05	70	35	4	M938
Pathway	REACTOME_BMAL1_CLOCK_NPAS2_ACTIVATES_CIRCADIAN_GENE_EXPRESSION	NCOA2 CHD9 NCOA6	3.94e-05	27	35	3	M26943
Pathway	REACTOME_TRANSCRIPTIONAL_REGULATION_OF_WHITE_ADIPOCYTE_DIFFERENTIATION	NCOA2 CHD9 NCOA6 EP300	5.34e-05	84	35	4	M1008
Pathway	REACTOME_ACTIVATION_OF_GENE_EXPRESSION_BY_SREBF_SREBP	NCOA2 CHD9 NCOA6	1.51e-04	42	35	3	M27172
Pathway	REACTOME_ADIPOGENESIS	NCOA2 CHD9 NCOA6 EP300	1.53e-04	110	35	4	M48259
Pathway	REACTOME_REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA	NCOA2 CHD9 NCOA6 EP300	2.00e-04	118	35	4	M27316
Pathway	REACTOME_TRANSCRIPTIONAL_ACTIVATION_OF_MITOCHONDRIAL_BIOGENESIS	NCOA2 CHD9 NCOA6	3.37e-04	55	35	3	M27145
Pathway	REACTOME_REGULATION_OF_CHOLESTEROL_BIOSYNTHESIS_BY_SREBP_SREBF	NCOA2 CHD9 NCOA6	3.37e-04	55	35	3	M27001
Pathway	REACTOME_CYTOPROTECTION_BY_HMOX1	NCOA2 CHD9 NCOA6	4.35e-04	60	35	3	M41830
Pathway	REACTOME_METABOLISM_OF_STEROIDS	NCOA2 CHD9 NCOA6 CUBN	5.51e-04	154	35	4	M27832
Pathway	REACTOME_REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA	NCOA2 CHD9	8.94e-04	18	35	2	MM15034
Pathway	REACTOME_SIGNALING_BY_PDGFR_IN_DISEASE	STRN KANK1	1.11e-03	20	35	2	M29849
Pathway	REACTOME_VITAMIN_B5_PANTOTHENATE_METABOLISM	ENPP1 ENPP2	1.11e-03	20	35	2	M538
Pathway	REACTOME_PKA_MEDIATED_PHOSPHORYLATION_OF_CREB	NBEA ADCY2	1.11e-03	20	35	2	M759
Pubmed	Structural and biochemical characterization of the human cyclophilin family of peptidyl-prolyl isomerases.	RANBP2 CWC27 PPIF	5.88e-07	15	39	3	20676357
Pubmed	Crystal structure of autotaxin and insight into GPCR activation by lipid mediators.	ENPP1 ENPP2	1.23e-06	2	39	2	21240269
Pubmed	Deficiency of alkaline SMase enhances dextran sulfate sodium-induced colitis in mice with upregulation of autotaxin.	ENPP7 ENPP2	1.23e-06	2	39	2	30087205
Pubmed	Substrate-specifying determinants of the nucleotide pyrophosphatases/phosphodiesterases NPP1 and NPP2.	ENPP1 ENPP2	1.23e-06	2	39	2	15096095
Pubmed	T0070907, a selective ligand for peroxisome proliferator-activated receptor gamma, functions as an antagonist of biochemical and cellular activities.	NCOA2 NCOA6 EP300	1.47e-06	20	39	3	11877444
Pubmed	Nuclear receptor-coregulator interaction profiling identifies TRIP3 as a novel peroxisome proliferator-activated receptor gamma cofactor.	NCOA2 NCOA6 EP300	1.71e-06	21	39	3	19596656
Pubmed	Dendrite development regulated by CREST, a calcium-regulated transcriptional activator.	EP300 SS18L1	3.67e-06	3	39	2	14716005
Pubmed	A conserved acetylation switch enables pharmacological control of tubby-like protein stability.	PJA2 CHD9 STRN EP300 ALG13	4.99e-06	223	39	5	33187986
Pubmed	Ataxin-3 is a histone-binding protein with two independent transcriptional corepressor activities.	EP300 ATXN3	7.34e-06	4	39	2	12297501
Pubmed	Synergy among nuclear receptor coactivators: selective requirement for protein methyltransferase and acetyltransferase activities.	NCOA2 EP300	7.34e-06	4	39	2	11997499
Pubmed	LPS-induced NFκB enhanceosome requires TonEBP/NFAT5 without DNA binding.	NFAT5 EP300	7.34e-06	4	39	2	27118681
Pubmed	Transcriptional synergy between melanoma antigen gene protein-A11 (MAGE-11) and p300 in androgen receptor signaling.	NCOA2 EP300	7.34e-06	4	39	2	20448036
Pubmed	A simple method to screen ligands of peroxisome proliferator-activated receptor delta.	NCOA2 EP300	7.34e-06	4	39	2	16930961
Pubmed	Transcriptional coactivator PRIP, the peroxisome proliferator-activated receptor gamma (PPARgamma)-interacting protein, is required for PPARgamma-mediated adipogenesis.	NCOA6 EP300	7.34e-06	4	39	2	12754253
Pubmed	Metastasis-associated protein 2 is a repressor of estrogen receptor alpha whose overexpression leads to estrogen-independent growth of human breast cancer cells.	NCOA2 EP300	1.22e-05	5	39	2	16645043
Pubmed	SRC-1 and GRIP1 coactivate transcription with hepatocyte nuclear factor 4.	NCOA2 EP300	1.22e-05	5	39	2	9812974
Pubmed	Interaction of PIMT with transcriptional coactivators CBP, p300, and PBP differential role in transcriptional regulation.	NCOA6 EP300	1.22e-05	5	39	2	11912212
Pubmed	Ligand-independent interactions of p160/steroid receptor coactivators and CREB-binding protein (CBP) with estrogen receptor-alpha: regulation by phosphorylation sites in the A/B region depends on other receptor domains.	NCOA2 EP300	1.22e-05	5	39	2	12714702
Pubmed	Identification and characterization of RRM-containing coactivator activator (CoAA) as TRBP-interacting protein, and its splice variant as a coactivator modulator (CoAM).	NCOA6 EP300	1.83e-05	6	39	2	11443112
Pubmed	Signaling within a coactivator complex: methylation of SRC-3/AIB1 is a molecular switch for complex disassembly.	NCOA2 EP300	1.83e-05	6	39	2	16923966
Pubmed	Regulation of coactivator complex assembly and function by protein arginine methylation and demethylimination.	NCOA2 EP300	1.83e-05	6	39	2	15731352
Pubmed	Chromatin remodelling by the glucocorticoid receptor requires the BRG1 complex.	NCOA2 EP300	2.56e-05	7	39	2	9590696
Pubmed	An additional region of coactivator GRIP1 required for interaction with the hormone-binding domains of a subset of nuclear receptors.	NCOA2 EP300	2.56e-05	7	39	2	9920895
Pubmed	The AF-1 domain of the orphan nuclear receptor NOR-1 mediates trans-activation, coactivator recruitment, and activation by the purine anti-metabolite 6-mercaptopurine.	NCOA2 EP300	2.56e-05	7	39	2	12709428
Pubmed	The activation function-1 domain of Nur77/NR4A1 mediates trans-activation, cell specificity, and coactivator recruitment.	NCOA2 EP300	3.42e-05	8	39	2	12082103
Pubmed	Concerted activation of ETS protein ER81 by p160 coactivators, the acetyltransferase p300 and the receptor tyrosine kinase HER2/Neu.	NCOA2 EP300	3.42e-05	8	39	2	14747462
Pubmed	Thyroid hormone receptor-binding protein, an LXXLL motif-containing protein, functions as a general coactivator.	NCOA6 EP300	3.42e-05	8	39	2	10823961
Pubmed	Regulation of hormone-induced histone hyperacetylation and gene activation via acetylation of an acetylase.	NCOA2 EP300	3.42e-05	8	39	2	10490106
Pubmed	Regulation of somatic growth by the p160 coactivator p/CIP.	NCOA2 EP300	4.39e-05	9	39	2	11087842
Pubmed	An acetylation switch regulates SUMO-dependent protein interaction networks.	RANBP2 EP300	4.39e-05	9	39	2	22578841
Pubmed	Interaction network of human early embryonic transcription factors.	NCOA2 NCOA6 RANBP2 EP300 SS18L1	4.42e-05	351	39	5	38297188
Pubmed	A transcriptional inhibitor targeted by the atypical orphan nuclear receptor SHP.	NCOA2 EP300	5.48e-05	10	39	2	11964378
Pubmed	The Hippocampal Response to Acute Corticosterone Elevation Is Altered in a Mouse Model for Angelman Syndrome.	NCOA2 NCOA6	6.70e-05	11	39	2	36613751
Pubmed	Prognostic implications of genetic variants in advanced non-small cell lung cancer: a genome-wide association study.	NCOA2 NALCN	6.70e-05	11	39	2	23144319
Pubmed	TNF-α inhibits glucocorticoid receptor-induced gene expression by reshaping the GR nuclear cofactor profile.	NCOA2 NCOA6 NBEA ADCY2 EP300 SS18L1	7.26e-05	638	39	6	31182584
Pubmed	Identification of a transcriptionally active peroxisome proliferator-activated receptor alpha -interacting cofactor complex in rat liver and characterization of PRIC285 as a coactivator.	NCOA6 EP300	8.03e-05	12	39	2	12189208
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	PJA2 KANK1 NFAT5 ADCY2 PCDH19	8.89e-05	407	39	5	12693553
Pubmed	The Arf family GTPase Arl4A complexes with ELMO proteins to promote actin cytoskeleton remodeling and reveals a versatile Ras-binding domain in the ELMO proteins family.	DOCK5 ADGRB1	9.48e-05	13	39	2	21930703
Pubmed	Identification of novel oocyte and granulosa cell markers.	NCOA2 TGFBR3	9.48e-05	13	39	2	19539053
Pubmed	Multiplexed molecular interactions of nuclear receptors using fluorescent microspheres.	NCOA2 EP300	1.11e-04	14	39	2	11500849
Pubmed	Activating signal cointegrator 2 belongs to a novel steady-state complex that contains a subset of trithorax group proteins.	NCOA2 NCOA6	1.11e-04	14	39	2	12482968
Pubmed	Identification of the SOX2 Interactome by BioID Reveals EP300 as a Mediator of SOX2-dependent Squamous Differentiation and Lung Squamous Cell Carcinoma Growth.	NCOA2 NCOA6 EP300	1.13e-04	83	39	3	28794006
Pubmed	SET1 and p300 act synergistically, through coupled histone modifications, in transcriptional activation by p53.	NCOA6 EP300	1.46e-04	16	39	2	23870121
Pubmed	Screening and association testing of common coding variation in steroid hormone receptor co-activator and co-repressor genes in relation to breast cancer risk: the Multiethnic Cohort.	NCOA2 EP300	1.65e-04	17	39	2	19183483
Pubmed	Adipocyte arrestin domain-containing 3 protein (Arrdc3) regulates uncoupling protein 1 (Ucp1) expression in white adipose independently of canonical changes in β-adrenergic receptor signaling.	NCOA6 EP300	1.65e-04	17	39	2	28291835
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	PJA2 CHD9 GARRE1 EP300 PCDH19 SS18L1 ALG13	2.15e-04	1116	39	7	31753913
Pubmed	ACAA2 is a ligand-dependent coactivator for thyroid hormone receptor β1.	CHD9 NCOA6 EP300	2.80e-04	113	39	3	34474245
Pubmed	Cranial neural crest deletion of VEGFa causes cleft palate with aberrant vascular and bone development.	TGFBR3 BMPR2	3.05e-04	23	39	2	25759071
Pubmed	Type III transforming growth factor beta receptor regulates vascular and osteoblast development during palatogenesis.	TGFBR3 BMPR2	3.33e-04	24	39	2	25382630
Pubmed	Endocardial Brg1 disruption illustrates the developmental origins of semilunar valve disease.	BMPR2 ENPP2	3.62e-04	25	39	2	26100917
Pubmed	Increased gene copy number of VAMP7 disrupts human male urogenital development through altered estrogen action.	NCOA2 EP300	4.55e-04	28	39	2	24880616
Pubmed	c-Jun is required for the specification of joint cell fates.	ENPP2 EP300	5.58e-04	31	39	2	23475960
Pubmed	Hnrnpk maintains chondrocytes survival and function during growth plate development via regulating Hif1α-glycolysis axis.	NFAT5 CNMD	5.58e-04	31	39	2	36127325
Pubmed	The Eyes Absent family members EYA4 and EYA1 promote PLK1 activation and successful mitosis through tyrosine dephosphorylation.	NCOA2 GARRE1 EP300	6.66e-04	152	39	3	38360978
Pubmed	Postmitotic Hoxa5 Expression Specifies Pontine Neuron Positional Identity and Input Connectivity of Cortical Afferent Subsets.	CDHR1 PCDH19	6.72e-04	34	39	2	32553152
Pubmed	RUNX1 and TGF-β signaling cross talk regulates Ca2+ ion channels expression and activity during megakaryocyte development.	TGFBR3 BMPR2	7.12e-04	35	39	2	32281291
Pubmed	Proteins associated with type II bone morphogenetic protein receptor (BMPR-II) and identified by two-dimensional gel electrophoresis and mass spectrometry.	NBEA BMPR2	7.12e-04	35	39	2	15188402
Pubmed	The Epigenetic Factor Landscape of Developing Neocortex Is Regulated by Transcription Factors Pax6→ Tbr2→ Tbr1.	NCOA6 EP300 SS18L1	7.32e-04	157	39	3	30186101
Pubmed	Construction of a multi-functional cDNA library specific for mouse pancreatic islets and its application to microarray.	PCDHB8 NCOA2 SGSM1 WDR36	7.80e-04	371	39	4	15747579
Pubmed	Defining the human deubiquitinating enzyme interaction landscape.	PJA2 STRN WDR36 SS18L1 ADGRB1 ATXN3	8.28e-04	1005	39	6	19615732
Pubmed	High-density association study of 383 candidate genes for volumetric BMD at the femoral neck and lumbar spine among older men.	NCOA2 TGFBR3 BMPR2 ENPP1	8.78e-04	383	39	4	19453261
Pubmed	Phase-separated nuclear bodies of nucleoporin fusions promote condensation of MLL1/CRM1 and rearrangement of 3D genome structure.	RANBP2 STRN	9.30e-04	40	39	2	37516964
Pubmed	Prediction of the coding sequences of unidentified human genes. V. The coding sequences of 40 new genes (KIAA0161-KIAA0200) deduced by analysis of cDNA clones from human cell line KG-1.	NCOA6 KANK1	9.77e-04	41	39	2	8724849
Pubmed	The Dual Estrogen Receptor α Inhibitory Effects of the Tissue-Selective Estrogen Complex for Endometrial and Breast Safety.	NCOA2 NCOA6	1.07e-03	43	39	2	26487511
Interaction	CAMKV interactions	GGH TGFBR3 CHD9 PNISR CWC27	3.10e-06	118	39	5	int:CAMKV
Interaction	NR1H3 interactions	NCOA6 STRN EP300 SS18L1	4.71e-06	58	39	4	int:NR1H3
Interaction	PPARA interactions	NCOA2 CHD9 NCOA6 EP300	2.96e-05	92	39	4	int:PPARA
Cytoband	Ensembl 112 genes in cytogenetic band chr5q21	PAM PJA2	1.59e-03	69	39	2	chr5q21
Cytoband	Ensembl 112 genes in cytogenetic band chrXq23	GUCY2F ALG13	2.63e-03	89	39	2	chrXq23
GeneFamily	Cyclophilin peptidylprolyl isomerases	RANBP2 CWC27 PPIF	2.52e-06	19	26	3	909
GeneFamily	Zinc fingers ZZ-type\|Lysine acetyltransferases	NCOA2 EP300	2.67e-04	17	26	2	486
GeneFamily	WD repeat domain containing	NBEA STRN WDR36	6.11e-03	262	26	3	362
Coexpression	LAKE_ADULT_KIDNEY_C2_PODOCYTES	DOCK5 TGFBR3 PAM BMPR2 KANK1	1.52e-05	212	39	5	M39221
Coexpression	BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP	PJA2 NCOA6 PNISR NFAT5 GARRE1 EP300 PPIF ATXN3	2.35e-05	822	39	8	M6782
Coexpression	NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_UP	GGH PJA2 CHD9 NCOA6 BMPR2 PNISR NFAT5 ENPP2 ALG13	5.77e-05	1215	39	9	M41122
Coexpression	BENPORATH_NOS_TARGETS	KANK1 WDR36 PNISR ENPP2	1.44e-04	179	39	4	M14573
Coexpression	GSE27291_6H_VS_7D_STIM_GAMMADELTA_TCELL_DN	NCOA2 CHD9 PCDH19 PPIF	1.70e-04	187	39	4	M8460
Coexpression	CHEBOTAEV_GR_TARGETS_UP	DOCK5 CHD9 ENPP1	2.06e-04	77	39	3	M4263
Coexpression	GSE18804_SPLEEN_MACROPHAGE_VS_BRAIN_TUMORAL_MACROPHAGE_DN	PAM CHD9 KANK1 PCDH19	2.07e-04	197	39	4	M10015
Coexpression	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN	PCDHB8 TGFBR3 STRN KANK1 CUBN PNISR ENPP2 PCDH19	2.10e-04	1124	39	8	MM1070
Coexpression	GSE18804_SPLEEN_MACROPHAGE_VS_TUMORAL_MACROPHAGE_DN	GGH CHD9 ENPP2 PCDH19	2.11e-04	198	39	4	M10020
Coexpression	GSE29618_PRE_VS_DAY7_POST_LAIV_FLU_VACCINE_MDC_UP	GGH KANK1 ENPP2 CNMD	2.11e-04	198	39	4	M5007
Coexpression	GSE29949_CD8_POS_DC_SPLEEN_VS_DC_BRAIN_UP	GGH NCOA6 BMPR2 PNISR	2.11e-04	198	39	4	M8407
Coexpression	GSE4984_LPS_VS_VEHICLE_CTRL_TREATED_DC_DN	NCOA2 TGFBR3 NCOA6 NFAT5	2.11e-04	198	39	4	M6511
Coexpression	GSE11961_MARGINAL_ZONE_BCELL_VS_GERMINAL_CENTER_BCELL_DAY40_UP	PAM NCOA6 STRN ENPP1	2.20e-04	200	39	4	M9317
Coexpression	GSE22025_UNTREATED_VS_PROGESTERONE_TREATED_CD4_TCELL_DN	RANBP2 BMPR2 ENPP1 ALG13	2.20e-04	200	39	4	M8384
Coexpression	GSE10325_BCELL_VS_LUPUS_BCELL_DN	GGH PJA2 NCOA6 PPIF	2.20e-04	200	39	4	M3095
Coexpression	CHEBOTAEV_GR_TARGETS_UP	DOCK5 CHD9 ENPP1	2.23e-04	79	39	3	MM469
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	NCOA2 TGFBR3 PJA2 CHD9 RANBP2 PNISR GARRE1	2.39e-04	856	39	7	M4500
CoexpressionAtlas	DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_1000	PJA2 CHD9 NBEA NALCN PNISR NFAT5 ENPP1 CNMD PCDH19	9.01e-06	801	38	9	gudmap_developingGonad_e14.5_ epididymis_1000
CoexpressionAtlas	DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_1000	PJA2 CHD9 NBEA NALCN PNISR NFAT5 ENPP1 CNMD	6.43e-05	790	38	8	gudmap_developingGonad_e16.5_epididymis_1000
CoexpressionAtlas	DevelopingKidney_e14.5 whole kidney - Wnt4 KO_emap-6674_top-relative-expression-ranked_1000	DOCK5 PAM NBEA PNISR NFAT5 ADCY2 ENPP1 PCDH19	6.48e-05	791	38	8	gudmap_developingKidney_e14.5 whole kidney - Wnt4 KO_1000
CoexpressionAtlas	DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#4_top-relative-expression-ranked_1000	NBEA NALCN PNISR ENPP1 PCDH19	8.88e-05	256	38	5	gudmap_developingGonad_e14.5_ epididymis_1000_k4
CoexpressionAtlas	DevelopingLowerUrinaryTract_P1_bladder_J_emap-30374_k-means-cluster#1_top-relative-expression-ranked_1000	TGFBR3 NFAT5 ZC3H6 ENPP1	1.43e-04	149	38	4	gudmap_developingLowerUrinaryTract_P1_bladder_J_1000_k1
ToppCell	facs-Heart-LV-3m-Endothelial-endothelial_cell_of_endocardium\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PCDHB8 BMPR2 KANK1 CDHR1 SS18L1	3.99e-07	172	39	5	f2c17c49b375b28ad47dc6cabda62f1c238023dd
ToppCell	facs-Heart-LV-3m-Endothelial-endocardial_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PCDHB8 BMPR2 KANK1 CDHR1 SS18L1	3.99e-07	172	39	5	6ab4f01098dddb789df298ddf97b3c384405ee6c
ToppCell	droplet-Trachea-nan-3m-Mesenchymal-nan\|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TGFBR3 PAM KANK1 ENPP2 CNMD	8.00e-07	198	39	5	d3a475be01657a03fcbb0ee0a246b1e90deacaa4
ToppCell	droplet-Trachea-3m-Mesenchymal\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	TGFBR3 PAM KANK1 ENPP2 CNMD	8.00e-07	198	39	5	1beed34f469aad07e8f674f0b668d6e1e916403c
ToppCell	droplet-Trachea-nan-3m-Mesenchymal\|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TGFBR3 PAM KANK1 ENPP2 CNMD	8.00e-07	198	39	5	985022c1722ab7b67675ebe814022a439e715b5e
ToppCell	facs-Trachea-nan-24m-Mesenchymal-chondrocyte\|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PAM KANK1 ENPP1 CNMD	1.56e-05	173	39	4	2226505610af1becc253d0a5550627144ef0ed6b
ToppCell	E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-Chondrocyte\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PAM KANK1 ENPP2 CNMD	1.64e-05	175	39	4	8b498eea1ec1c1f27b171025c3d08adf3687bafc
ToppCell	E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-Chondrocyte-Chondrocyte_mature\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PAM KANK1 ENPP2 CNMD	1.64e-05	175	39	4	a5db428b078938627e61b7e944c1e0c1d61ac2da
ToppCell	droplet-Heart-nan-3m\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PAM CHD9 RANBP2 BMPR2	1.67e-05	176	39	4	749b47eac5436fa34e0d243ffbc6f1897f4e431e
ToppCell	Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-6_VIP_VIP\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	TGFBR3 KANK1 CDHR1 PCDH19	1.79e-05	179	39	4	01302505816f272243659e20d751b61a198a2fc0
ToppCell	PND07-28-samps-Mesenchymal-Myofibroblast-myofibroblast_-_mature_-_C\|PND07-28-samps / Age Group, Lineage, Cell class and subclass	TGFBR3 PAM KANK1 ENPP2	2.03e-05	185	39	4	427176ad9ab8d9511200fb0a132cfd1e835fe35c
ToppCell	TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1\|TCGA-Pancreas / Sample_Type by Project: Shred V9	NCOA2 BMPR2 NFAT5 EP300	2.08e-05	186	39	4	03db813598b67b1e08f759758a1c2023396921fa
ToppCell	facs-Lung-nan-3m-Mesenchymal-pulmonary_interstitial_fibroblast\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TGFBR3 ADCY2 ENPP1 ENPP2	2.26e-05	190	39	4	c7bd087f36321cec61b98657433b4d19d135791f
ToppCell	facs-Lung-nan-3m-Mesenchymal-Myofibroblast\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TGFBR3 ADCY2 ENPP1 ENPP2	2.26e-05	190	39	4	834218fcc59df5e7e52de154272f3d55d81d0dac
ToppCell	droplet-Lung-LUNG-1m-Mesenchymal-Myofibroblast\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TGFBR3 PAM ENPP1 ENPP2	2.30e-05	191	39	4	9d3fa8d8138700640cc7927521c7635299df697d
ToppCell	facs-Lung-3m-Mesenchymal-myofibroblast\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	TGFBR3 ADCY2 ENPP1 ENPP2	2.30e-05	191	39	4	fd8331c7abdd999f55ba43d307945c6abfccbf84
ToppCell	droplet-Lung-LUNG-1m-Mesenchymal-pulmonary_interstitial_fibroblast\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TGFBR3 PAM ENPP1 ENPP2	2.30e-05	191	39	4	d04ed1e04b8cb904237d8e8388fe7740c724237b
ToppCell	droplet-Lung-1m-Mesenchymal-myofibroblast-myofibroblast_cell-pulmonary_interstitial_myofibroblast\|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	TGFBR3 PAM CUBN ENPP2	2.40e-05	193	39	4	2b80991e7ba7640f7ab2139d30e4c54d8e533862
ToppCell	(2)_5-FU-(2)_LEPR+_perivascular_cells_and_VE-Cad+_vascular_cells_(mixed)\|World / Stress and Cell class	GGH TGFBR3 PAM ENPP2	2.40e-05	193	39	4	f31398dad5321a7bcb27e208bd73630e9756e897
ToppCell	droplet-Lung-1m-Mesenchymal-myofibroblast-myofibroblast_cell\|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	TGFBR3 PAM CUBN ENPP2	2.40e-05	193	39	4	90cfc34c2d0d7c70f071703d35db1d6037961481
ToppCell	P28-Mesenchymal-myocytic_cell-aortic_smooth_muscle_cell\|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	TGFBR3 PAM ENPP1 ENPP2	2.45e-05	194	39	4	3c661c6768c3f05d2aba03d329adb257ca201b2d
ToppCell	P15-Mesenchymal-myocytic_cell-aortic_smooth_muscle_cell\|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	TGFBR3 PAM ENPP1 ENPP2	2.45e-05	194	39	4	5f04d21c4e2d36e74b6c5889aa97fd98f75a0973
ToppCell	(6)_Endothelial-B_(Artery)\|World / Lung cell shreds - cell class (v4) and cell subclass (v4)	BMPR2 CUBN GARRE1 ENPP2	2.45e-05	194	39	4	0cf4e67d4024652794b5bfdd4a71a7d98900b4c8
ToppCell	facs-Lung-3m-Mesenchymal-myofibroblast-myofibroblast_cell\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	TGFBR3 ADCY2 ENPP1 ENPP2	2.50e-05	195	39	4	c6bb16c0076639c6ddef1a15d8cba44bc29c077d
ToppCell	facs-Lung-3m-Mesenchymal-myofibroblast-myofibroblast_cell-pulmonary_interstitial_myofibroblast\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	TGFBR3 ADCY2 ENPP1 ENPP2	2.50e-05	195	39	4	ea89f80d3d7e9f737442f7c1aa1791d277ffc90c
ToppCell	droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TGFBR3 CHD9 BMPR2 ENPP2	2.50e-05	195	39	4	5c86fddd6d0530beecf45ea5ba6b823123847696
ToppCell	facs-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l34\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	PAM KANK1 ENPP1 CNMD	2.60e-05	197	39	4	6e111ba16fc8adde782b3f7da250248cddf11228
ToppCell	facs-Trachea-3m-Mesenchymal-myofibroblast\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	PAM KANK1 ENPP1 CNMD	2.60e-05	197	39	4	ece0c17eb68f394b20e588c0b0626d3987a4dbbb
ToppCell	droplet-Trachea-nan-3m-Mesenchymal-chondrocyte\|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PAM KANK1 ENPP2 CNMD	2.60e-05	197	39	4	8786125b669d5d0b15e12df0ade6b319f09f7333
ToppCell	facs-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	PAM KANK1 ENPP1 CNMD	2.60e-05	197	39	4	4b6c0e028b9669c102df8e9dc63e284f8d5fd9ee
ToppCell	facs-Trachea-nan-3m-Mesenchymal-chondrocyte\|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PAM KANK1 ENPP1 CNMD	2.65e-05	198	39	4	71e847e8c24744d6df4a960348ad2ecf310373b4
ToppCell	droplet-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l34\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	PAM KANK1 ENPP2 CNMD	2.65e-05	198	39	4	3575620db5aeaeb0bdcd7a8ff65c43abd3fa13e4
ToppCell	control-Epithelial-Secretory\|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	PAM CHD9 PNISR NFAT5	2.71e-05	199	39	4	3d01f90ffd271ca00129192787e4921bdca7e01e
ToppCell	Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_3-GGH-L1-3\|Neuronal / cells hierarchy compared to all cells using T-Statistic	GGH KANK1 CDHR1 PCDH19	2.76e-05	200	39	4	48303e499251d6754cfa991dc2d96c5563b2123c
ToppCell	Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_3-GGH\|Neuronal / cells hierarchy compared to all cells using T-Statistic	GGH KANK1 CDHR1 PCDH19	2.76e-05	200	39	4	4802dd6cae84b41746227a5d1aa1c9b858495e36
ToppCell	droplet-Pancreas-Endocrine-21m-Epithelial-pancreatic_acinar_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GGH PNLIPRP1 ADGRB1	8.39e-05	97	39	3	16947da747504c2edb9f2e7ee6f05babda0fae60
ToppCell	droplet-Pancreas-Endocrine-21m-Epithelial-pancreatic_acinar_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GGH PNLIPRP1 ADGRB1	1.09e-04	106	39	3	3aa55c3db4e4abd39c8f2f89f2516927d94ad9d7
ToppCell	primary_visual_cortex-Neuronal-GABAergic_neuron-Serpinf1\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	PNLIPRP1 ENPP1 ENPP2	1.54e-04	119	39	3	9ffdb432ec06d12eccbc9af9d30c0d24a0a21030
ToppCell	Brain_organoid-organoid_Kanton_Nature-Organoid-2M-Stem_cells-neuroepithelial-like_cells\|Organoid-2M / Sample Type, Dataset, Time_group, and Cell type.	NCOA2 DOCK5 KANK1	1.86e-04	127	39	3	9071cd0953c8bb6746dc9cd13d153e3d6ef40b08
ToppCell	Severe-B_intermediate-14\|World / disease group and sub_cluster of B and Plasma cells(res = 0.5)	DOCK5 ZNF613 ENPP2	2.59e-04	142	39	3	9c7d5783302974b883bd887f997d094eb5925ec2
ToppCell	primary_visual_cortex-Neuronal-glutamatergic_neuron-NP-L5_NP_VISp_Trhr_Met\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	ADCY2 CDHR1 PCDH19	2.75e-04	145	39	3	8abbc781f5f69f039617c29a5589d7b6950c2c40
ToppCell	Substantia_nigra-Macroglia-POLYDENDROCYTE\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	KANK1 ENPP2 CNMD	3.04e-04	150	39	3	70ac8ae4b1683fb17278a8e4606f2fa0b94988c0
ToppCell	Adult-Mesenchymal-myofibroblast_cell-D122\|Adult / Lineage, Cell type, age group and donor	TGFBR3 NALCN ADCY2	3.54e-04	158	39	3	410fa08c9d880d27e80ec939fa5ba5a41dcb31ab
ToppCell	facs-Marrow-T_cells-18m-Lymphocytic-immature_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GGH ENPP1 ADGRB1	3.81e-04	162	39	3	22f1abd20f43bc7e7fc46969da9962faf70ae5d2
ToppCell	facs-Marrow-T_cells-18m-Lymphocytic-immature_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GGH ENPP1 ADGRB1	3.81e-04	162	39	3	966df4558140c3d541999ab553f201ae76a1c401
ToppCell	facs-Brain_Non-Myeloid-Cortex_-18m-Epithelial-neuronal_stem_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KANK1 CUBN CNMD	3.95e-04	164	39	3	0853e75b60b2a78257b660910c3ee15b09c5f5b0
ToppCell	Children_(3_yrs)-Epithelial-lung_neuroendocrine_cell_(PNEC)-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	NALCN ADCY2 CNMD	3.95e-04	164	39	3	be49af6335f2505065cde2cb9800e4a5516811b1
ToppCell	Thalamus-Macroglia-POLYDENDROCYTE\|Thalamus / BrainAtlas - Mouse McCarroll V32	KANK1 ENPP2 CNMD	4.16e-04	167	39	3	1e144c03409df94ccd39760842590e8ea7487e29
ToppCell	Control-NK\|Control / Disease group and Cell class	DOCK5 ENPP1 CDHR1	4.23e-04	168	39	3	683d389c8a1e791bfc773e63148115a21a6566db
ToppCell	droplet-Heart-nan\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TGFBR3 PAM KANK1	4.31e-04	169	39	3	2e5bb6437bc9c614e337c5ffb6f6457cd9fc7f4c
ToppCell	T_cells-GNLY+GZMB+_T_cells\|T_cells / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues	DOCK5 TGFBR3 SGSM1	4.46e-04	171	39	3	04c811817cfec45af5f2891793106cc7ddb0300e
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-immature_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PCDHB8 GGH KANK1	4.61e-04	173	39	3	e944ea3a0a368f856efacbda4600605cf751dd9c
ToppCell	facs-Lung-EPCAM-3m-Mesenchymal-pericyte_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADCY2 ENPP2 PCDH19	4.61e-04	173	39	3	3059325901b1e5e12a1a91183f14267288b2f600
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-immature_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PCDHB8 GGH KANK1	4.61e-04	173	39	3	85fa5918e9c1f6bb4757e3350cfc71ee75c55640
ToppCell	3'-Adult-SmallIntestine-Endothelial-blood_vessel_EC-Mature_venous_EC\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	GARRE1 ENPP2 PCDH19	4.61e-04	173	39	3	b57d14e2c2368304cb903562d06ce8228f53857c
ToppCell	facs-Lung-EPCAM-3m-Mesenchymal-Pericyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADCY2 ENPP2 PCDH19	4.61e-04	173	39	3	36c8338463ee4cc432f568728d55989360f9a68d
ToppCell	facs-Lung-Endomucin_-18m-Endothelial-Lymphatic_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SGSM1 CWC27 CDHR1	4.77e-04	175	39	3	0801cccec6915aefc135262fc74580280fd51aa5
ToppCell	facs-Lung-3m-Mesenchymal-myofibroblast-pericyte_cell-pericyte\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ADCY2 ENPP2 PCDH19	4.77e-04	175	39	3	fb91a45763e4c48d993094a13088ffc19f1e2574
ToppCell	facs-Lung-Endomucin_-18m-Endothelial-endothelial_cell_of_lymphatic_vessel\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SGSM1 CWC27 CDHR1	4.77e-04	175	39	3	09163e7030f76d706eccabdb1d5ec45f8412aa75
ToppCell	P15-Mesenchymal-mesenchymal_fibroblast-tracheal_fibroblast\|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	KANK1 ENPP1 CNMD	4.77e-04	175	39	3	085cceb1fc2c4ae2f27e85cea5702defecc2cf44
ToppCell	facs-Lung-3m-Mesenchymal-myofibroblast-pericyte_cell\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ADCY2 ENPP2 PCDH19	4.77e-04	175	39	3	2a53d4f140d5ab096efe8118d8aa351db7838b49
ToppCell	(0)_Normal/No_Treatment-(3)_LEPR+_perivascular_cells\|World / Stress and Cell class	TGFBR3 PAM ENPP1	4.85e-04	176	39	3	ce2c32b5ce0da848eb4da35ce4d215cdf74d9113
ToppCell	facs-Trachea-24m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l34\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	KANK1 ENPP1 CNMD	4.85e-04	176	39	3	77c3da2eaa072a6baefb5087fd07ec18c5e271cd
ToppCell	CV-Severe-7\|CV / Virus stimulation, Condition and Cluster	PAM WDR36 NFAT5	4.85e-04	176	39	3	3de0c7d77210049e5616db21eed1490a17a5ec2d
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	NALCN ADCY2 ENPP1	4.93e-04	177	39	3	9ec7f1e64312d26d434b3312b58386715dbad644
ToppCell	CV-Severe-7\|Severe / Virus stimulation, Condition and Cluster	PAM WDR36 NFAT5	4.93e-04	177	39	3	82fdd6185b368f54f03de389427cbe3071d21a99
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	NALCN ADCY2 ENPP1	4.93e-04	177	39	3	016277dfd59b1793fddaaadc2b3f41622d76ce3a
ToppCell	P03-Mesenchymal-mesenchymal_fibroblast-tracheal_fibroblast\|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	KANK1 ENPP1 CNMD	5.01e-04	178	39	3	8591a40fced747ac16b3e8ebc7a22dfb3ad76da2
ToppCell	(3)_Chondrocytes-(32)_Chondro-prehyper-2\|World / Cell class and subclass of bone marrow stroma cells in homeostatis	ENPP2 CNMD PPIF	5.01e-04	178	39	3	c569a406c3ae183a278d8540e8eba58f4f26c5b0
ToppCell	3'-Adult-Distal_Rectal-Endothelial-blood_vessel_EC-Mature_arterial_EC\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	BMPR2 GARRE1 ENPP2	5.01e-04	178	39	3	c30d3390fc4a7856f50ba8ff6694c0333165ddde
ToppCell	Globus_pallidus-Macroglia-POLYDENDROCYTE\|Globus_pallidus / BrainAtlas - Mouse McCarroll V32	KANK1 ENPP2 CNMD	5.01e-04	178	39	3	b1357ceb84b83fab53c0394c1af73cbd009f571a
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	DOCK5 TGFBR3 NALCN	5.09e-04	179	39	3	7394e77e665bf16d3733df91bb12907be460ab44
ToppCell	facs-Lung-nan-3m-Mesenchymal-Pericyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADCY2 ENPP2 PCDH19	5.09e-04	179	39	3	7078022e60faa86444f2a2c6eb9f767cc66b5cfa
ToppCell	facs-Lung-nan-3m-Mesenchymal-pericyte_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADCY2 ENPP2 PCDH19	5.09e-04	179	39	3	d4a975d8ffa5e77fb5c0ec05bf9c8f843c77ce07
ToppCell	droplet-Limb_Muscle-Pre-Sort\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PAM KANK1 PNLIPRP1	5.18e-04	180	39	3	af2bafcd1b2082629de3ea336711add01565c4c4
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c01-FCGR3A\|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k)	DOCK5 TGFBR3 NBEA	5.18e-04	180	39	3	12f3c4c4aa7fe03c0ef847bd4d4942c808015f5f
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_ILC\|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k)	DOCK5 TGFBR3 NBEA	5.18e-04	180	39	3	2a28fbfe10a340c8662c2c8be33792f41fc09088
ToppCell	droplet-Limb_Muscle-Pre-Sort-18m\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PAM KANK1 PNLIPRP1	5.18e-04	180	39	3	f29a995cf6e1a1836ed68b73258d9370bf3d4434
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-6_VIP_VIP\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	TGFBR3 KANK1 PCDH19	5.18e-04	180	39	3	c6030e725e3d86d5d74a1676330c77ffeceb324f
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_ILC-NK_cell\|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k)	DOCK5 TGFBR3 NBEA	5.18e-04	180	39	3	1bc01bb76d0d3f8db74f9244436d3e6d6015ed5d
ToppCell	wk_15-18-Mesenchymal-Chondrocyte\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	ENPP1 ENPP2 CNMD	5.26e-04	181	39	3	8950844b3e65c7028d80da5787ae2ce509c3d52d
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	DOCK5 TGFBR3 NALCN	5.26e-04	181	39	3	5bf7aa43f6e6ecce15c95928b91195544d6928c4
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	DOCK5 TGFBR3 NALCN	5.26e-04	181	39	3	8e751f5d7cd2d328ec0196d874e8a507e8c4e1a9
ToppCell	droplet-Liver-Npc-21m-Endothelial\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TGFBR3 NBEA GARRE1	5.35e-04	182	39	3	dc55de945c6f78f32eb3a1b3520835eb8417e068
ToppCell	10x3'2.3-week_12-13-Mesenchymal_osteo-stroma-chondrocyte\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	PAM ENPP1 CNMD	5.35e-04	182	39	3	ed487f3a774812caa2903a646b60c86edcc1e65e
ToppCell	droplet-Liver-Npc-21m-Endothelial-endothelial_cell_of_hepatic_sinusoid\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TGFBR3 NBEA GARRE1	5.35e-04	182	39	3	010a7364da46101cb5068891fd7bc712ea8f13bd
ToppCell	droplet-Liver-Npc-21m-Endothelial-endothelial_cell_of_hepatic_sinusoid\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TGFBR3 NBEA GARRE1	5.35e-04	182	39	3	b1ec2015aad1181eac1bbf8d48ad6f2f7ed24a01
ToppCell	Adult-Mesenchymal-airway_smooth_muscle_cell-D175\|Adult / Lineage, Cell type, age group and donor	SGSM1 ENPP1 ENPP2	5.35e-04	182	39	3	ad4d74d8b19976e1ccc3c5ba8013199338cf6fd8
ToppCell	IPF-Myeloid-DC_Langerhans\|World / Disease state, Lineage and Cell class	DOCK5 ENPP1 ENPP2	5.35e-04	182	39	3	0e8cfbd8ea196f27a227dbb4d2eb93bc48d27922
ToppCell	E18.5-samps-Mesenchymal-Myofibroblast\|E18.5-samps / Age Group, Lineage, Cell class and subclass	TGFBR3 KANK1 ENPP2	5.43e-04	183	39	3	de08f9ea02b7244d5a8788064631d10f06565337
ToppCell	droplet-Lung-nan-21m-Mesenchymal-pulmonary_interstitial_fibroblast\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KANK1 CUBN ENPP2	5.43e-04	183	39	3	19e7be1cfdd111bfb840532a6f7c780345dffccf
ToppCell	3'-Adult-SmallIntestine-Endothelial\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	GARRE1 ENPP2 PCDH19	5.43e-04	183	39	3	f8212bf8a8b8312434ae030261c558c147f61747
ToppCell	Control-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DOCK5 TGFBR3 NALCN	5.43e-04	183	39	3	7eae9b3b4d1c9b135fa7cff348393d4adec474b4
ToppCell	droplet-Lung-nan-21m-Mesenchymal-Myofibroblast\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KANK1 CUBN ENPP2	5.43e-04	183	39	3	b153425ab0df1e5fa9b953e1f6d4e8e3dc6621b0
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	DOCK5 TGFBR3 KANK1	5.43e-04	183	39	3	3c516fe5083f02bad1f464ed284010b4131a833c
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L3-6_VIP_KCTD13\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	KANK1 CDHR1 PCDH19	5.43e-04	183	39	3	f06c06c75aab55fa8c803665afaa399446aec5af
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	DOCK5 TGFBR3 NALCN	5.43e-04	183	39	3	7c4b775f351794a3de06bd503eecbc8ae8577c44
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	DOCK5 TGFBR3 NALCN	5.43e-04	183	39	3	848fc6dd129150897ee339343e83c645b6e779eb
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	DOCK5 TGFBR3 KANK1	5.43e-04	183	39	3	9c2689d76fc6d30f5ab093428aa669d0a98953cf
ToppCell	3'-Adult-SmallIntestine-Endothelial-blood_vessel_EC\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	GARRE1 ENPP2 PCDH19	5.43e-04	183	39	3	858682df5592c6856487487a7baabd6e60e63a38
Drug	AC1L9A6V	NCOA6 ENPP7 ENPP1 ENPP2	2.90e-07	33	39	4	CID000440919
Drug	AC1L22FJ	NCOA2 DOCK5 NCOA6 CWC27 EP300 ATXN3	1.58e-06	213	39	6	CID000013766
Drug	RI-64	ENPP1 ENPP2	8.57e-06	3	39	2	CID000065758
Drug	4mupt	ENPP1 ENPP2	8.57e-06	3	39	2	CID000196156
Drug	phenylphosphonic dichloride	ENPP1 ENPP2	8.57e-06	3	39	2	CID000069990
Drug	quinovic acid	ENPP1 ENPP2	8.57e-06	3	39	2	CID000120678
Drug	Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA	NCOA2 NCOA6 KANK1 PNISR EP300	1.03e-05	170	39	5	1050_DN
Drug	benzoylsalireposide	ENPP1 ENPP2	1.71e-05	4	39	2	CID000639684
Drug	hebucol	ENPP1 ENPP2	1.71e-05	4	39	2	CID000072065
Drug	TCPOBOP	NCOA2 NCOA6 ENPP1 EP300	2.09e-05	95	39	4	CID000005382
Drug	Doxylamine succinate [562-10-7]; Up 200; 10.2uM; HL60; HG-U133A	PAM CHD9 KANK1 NFAT5 ENPP2	2.19e-05	199	39	5	1973_UP
Drug	8-acetyl-2-(dipropylamino)tetralin	ENPP1 ENPP2	2.85e-05	5	39	2	CID000132276
Drug	3,5-heptanedione	ENPP1 ENPP2	2.85e-05	5	39	2	CID000081923
Drug	phosphonic acid	GGH PNLIPRP1 ENPP1 ENPP2	3.59e-05	109	39	4	CID003084169
Drug	saterinone	ENPP1 ENPP2	4.27e-05	6	39	2	CID000065874
Drug	diadenosine diphosphate	ENPP1 ENPP2	4.27e-05	6	39	2	CID000188326
Drug	4-methylumbelliferyl phenylphosphonate	ENPP1 ENPP2	4.27e-05	6	39	2	CID000134928
Drug	NSC343256	ENPP1 ENPP2	4.27e-05	6	39	2	CID000335091
Drug	AC1L6XCD	ENPP1 ENPP2	4.27e-05	6	39	2	CID000325952
Drug	1-dodecanoyllysolecithin	ENPP1 ENPP2	5.97e-05	7	39	2	CID000460605
Drug	11-keto-beta-boswellic acid	ENPP1 ENPP2	7.95e-05	8	39	2	CID006918114
Drug	cadeguomycin	ENPP1 ENPP2	1.02e-04	9	39	2	CID000133738
Drug	ddUMP	ENPP1 ENPP2	1.02e-04	9	39	2	CID003081662
Drug	milrinone	ENPP7 GUCY2F ENPP1 ENPP2	1.24e-04	150	39	4	CID000004197
Drug	NSC285223	ENPP1 ENPP2	1.28e-04	10	39	2	CID000323607
Drug	2-(p-n-butylanilino)-2'-deoxyadenosine	ENPP1 ENPP2	1.28e-04	10	39	2	CID003062886
Drug	1-acetyl-sn-glycero-3-phosphocholine	PAM ENPP7 PNLIPRP1 ENPP1 ENPP2	1.65e-04	305	39	5	CID005311264
Drug	BuAdATP	ENPP1 ENPP2	1.87e-04	12	39	2	CID000127308
Drug	ciprofibrate	GGH CHD9 NCOA6 PPIF	2.01e-04	170	39	4	CID000002763
Drug	glycerol-3-phosphocholine	ENPP7 NFAT5 ENPP1 ENPP2	2.10e-04	172	39	4	CID000000823
Drug	PdNP	ENPP1 ENPP2	2.20e-04	13	39	2	CID000151930
Drug	Trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A_EA	NCOA2 NCOA6 PNISR EP300	2.25e-04	175	39	4	1014_DN
Drug	sodium glycocholate	ENPP7 ENPP1 ENPP2	2.25e-04	69	39	3	CID000000755
Drug	papaverine	ENPP7 GUCY2F ENPP1 ENPP2	2.30e-04	176	39	4	CID000004680
Drug	SAHA; Down 200; 10uM; MCF7; HT_HG-U133A	NCOA2 NCOA6 PNISR EP300	2.35e-04	177	39	4	1645_DN
Drug	FP-1	NCOA6 ENPP1 EP300	2.35e-04	70	39	3	CID000469561
Drug	LY 294002; Up 200; 10uM; MCF7; HT_HG-U133A_EA	STRN PNISR GARRE1 ATXN3	2.56e-04	181	39	4	1077_UP
Drug	ddUrd	ENPP1 ENPP2	2.57e-04	14	39	2	CID000065161
Drug	Probestin	ENPP1 ENPP2	2.57e-04	14	39	2	CID000130013
Drug	hemi-BABIM	NCOA6 ENPP1 ADGRB1	2.88e-04	75	39	3	CID000001281
Drug	cytochalasin B; Down 200; 20.8uM; MCF7; HT_HG-U133A_EA	NCOA2 PNISR SS18L1 PPIF	2.89e-04	187	39	4	1122_DN
Drug	Nppp	ENPP1 ENPP2	2.96e-04	15	39	2	CID003080789
Drug	Pinacidil [85371-64-8]; Down 200; 16.4uM; MCF7; HT_HG-U133A	NCOA2 DOCK5 STRN ALG13	3.14e-04	191	39	4	5456_DN
Drug	wortmannin; Down 200; 1uM; MCF7; HT_HG-U133A_EA	CHD9 KANK1 PNISR PPIF	3.20e-04	192	39	4	977_DN
Drug	Tolazamide [1156-19-0]; Up 200; 12.8uM; HL60; HT_HG-U133A	NBEA GUCY2F ENPP1 CNMD	3.26e-04	193	39	4	2482_UP
Drug	(-) -Levobunolol hydrochloride [27912-14-7]; Down 200; 12.2uM; MCF7; HT_HG-U133A	NCOA2 DOCK5 BMPR2 NFAT5	3.33e-04	194	39	4	4134_DN
Drug	Chlorthalidone [77-36-1]; Down 200; 11.8uM; HL60; HG-U133A	RANBP2 NFAT5 ENPP2 ALG13	3.33e-04	194	39	4	1581_DN
Drug	AC1L1GZ2	ENPP1 ENPP2	3.38e-04	16	39	2	CID000003905
Drug	dG-C8-PhIP	ENPP1 ENPP2	3.38e-04	16	39	2	CID000132509
Drug	Cephalothin sodium salt [58-71-9]; Down 200; 9.6uM; HL60; HT_HG-U133A	NCOA2 KANK1 NFAT5 ALG13	3.39e-04	195	39	4	2517_DN
Drug	Oleandomycin phosphate [7060-74-4]; Down 200; 5uM; MCF7; HT_HG-U133A	DOCK5 TGFBR3 GARRE1 ALG13	3.46e-04	196	39	4	5676_DN
Drug	Gemfibrozil [25812-30-0]; Up 200; 16uM; MCF7; HT_HG-U133A	NCOA2 TGFBR3 STRN ADCY2	3.46e-04	196	39	4	5488_UP
Drug	Pyrimethamine [58-14-0]; Up 200; 16uM; PC3; HG-U133A	PJA2 PNISR EP300 CNMD	3.46e-04	196	39	4	1894_UP
Drug	Butamben [94-25-7]; Down 200; 20.6uM; HL60; HT_HG-U133A	BMPR2 NFAT5 ENPP1 ENPP2	3.46e-04	196	39	4	2531_DN
Drug	Xylometazoline hydrochloride [1218-35-5]; Down 200; 14.2uM; HL60; HG-U133A	PAM EP300 ALG13 ATXN3	3.46e-04	196	39	4	1423_DN
Drug	CP-863187 [668981-07-5]; Up 200; 10uM; PC3; HT_HG-U133A	NCOA2 PNISR ENPP1 ATXN3	3.46e-04	196	39	4	7558_UP
Drug	Isoniazid [54-85-3]; Up 200; 29.2uM; HL60; HG-U133A	GGH NFAT5 ENPP2 EP300	3.46e-04	196	39	4	1399_UP
Drug	Betamethasone-d5	NCOA2 TGFBR3 WDR36 PNLIPRP1 ADCY2 ENPP1 ENPP2 EP300 PPIF	3.50e-04	1340	39	9	CID000003003
Drug	LY 294002; Down 200; 0.1uM; MCF7; HT_HG-U133A	CHD9 BMPR2 NFAT5 ATXN3	3.53e-04	197	39	4	6935_DN
Drug	Gliclazide [21187-98-4]; Down 200; 12.4uM; MCF7; HT_HG-U133A	BMPR2 NFAT5 GARRE1 ATXN3	3.53e-04	197	39	4	2870_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	NCOA2 PNISR EP300 ALG13	3.60e-04	198	39	4	3332_DN
Drug	Tremorine dihydrochloride [300-68-5]; Down 200; 15uM; HL60; HG-U133A	PAM CHD9 ENPP2 ALG13	3.60e-04	198	39	4	1579_DN
Drug	W-13, hydrochloride; Down 200; 10uM; MCF7; HG-U133A	NCOA2 DOCK5 PAM ENPP2	3.60e-04	198	39	4	440_DN
Drug	Dapsone [80-08-0]; Down 200; 16.2uM; HL60; HT_HG-U133A	DOCK5 TGFBR3 KANK1 NFAT5	3.60e-04	198	39	4	1868_DN
Drug	Tetrandrine [518-34-3]; Down 200; 6.4uM; MCF7; HT_HG-U133A	NCOA2 KANK1 NFAT5 ENPP1	3.60e-04	198	39	4	7178_DN
Drug	ddUTP	ENPP1 ENPP2	4.30e-04	18	39	2	CID000072245
Disease	response to atorvastatin, myopathy	ADCY2 GARRE1	1.32e-04	13	39	2	EFO_0004145, EFO_0010124
Disease	Malignant neoplasm of breast	NCOA2 NCOA6 BMPR2 CUBN PNLIPRP1 GUCY2F EP300	4.60e-04	1074	39	7	C0006142
Disease	suicidal ideation	NCOA2 WDR36	6.76e-04	29	39	2	EFO_0004320
Disease	stomach cancer (is_marker_for)	NCOA2 NBEA ADGRB1	8.78e-04	142	39	3	DOID:10534 (is_marker_for)
Disease	nasal disorder	PJA2 WDR36	9.85e-04	35	39	2	MONDO_0002436
Disease	diverticulitis	NBEA CWC27	1.10e-03	37	39	2	EFO_1001460
Disease	prostate cancer (is_marker_for)	NCOA2 PNLIPRP1 EP300	1.15e-03	156	39	3	DOID:10283 (is_marker_for)
Disease	Carcinoma, Transitional Cell	GGH EP300	1.35e-03	41	39	2	C0007138
Disease	glioblastoma (is_marker_for)	ENPP1 ADGRB1	1.55e-03	44	39	2	DOID:3068 (is_marker_for)
Disease	uterine fibroid	NCOA2 DOCK5 KANK1	2.31e-03	199	39	3	EFO_0000731

Protein segments in the cluster

Peptide	Gene	Start	Entry
ANPMEQGHFASPDQN	EP300	2356	Q09472
QGHFASPDQNSMLSQ	EP300	2361	Q09472
HFFDNGVGSTNGNMA	CDHR1	26	Q96JP9
QTAGNVMSNEHFHPQ	ALG13	631	Q9NP73
MANAGSHDNGSQFFF	CWC27	101	Q6UX04
GGSFQNGHAQLMTDF	ADGRB1	1211	O14514
GDQEPVQGFVMNFSN	PAM	751	P19021
FGHVDQENSPSFMFQ	RANBP2	1861	P49792
SMGSQMPDHDQNEGF	PCDH19	941	Q8TAB3
FLQQPSGNMDDSGFF	ATXN3	61	P54252
NQQMGHLDFFPNGGE	PNLIPRP1	236	P54315
AFGEPHSQMGSLNSQ	KANK1	851	Q14678
GSGFHGSDNVFSNMQ	ENPP1	531	P22413
MQHSGDNQPQVNLFS	NFAT5	1011	O94916
AHTNFPQMSNPGQFT	NCOA6	386	Q14686
MFVQFISDHSNEGQG	CUBN	2191	O60494
GPKAGQMENTNNFHN	ADCY2	266	Q08462
SHQEGNFNGPSPNMT	CHD9	246	Q3L8U1
FNFSGNGNFHMFENE	DOCK5	1136	Q9H7D0
GGQLHSRMFQNFPTE	GGH	166	Q92820
QFHGFNQLMRTDSNG	GUCY2F	386	P51841
DFLSGFNMGQSHQGS	GARRE1	651	O15063
FQTEVGNHPTFEDMQ	BMPR2	436	Q13873
VQFNNGEHGFDNKDM	ENPP7	346	Q6UWV6
FQGDHGFDNKVNSMQ	ENPP2	471	Q13822
QGHSFGPEMEQNSNF	PCDHB8	776	Q9UN66
GPEMEQNSNFRNGFG	PCDHB8	781	Q9UN66
MDEQAGPGVFFSNNH	STRN	1	O43815
NQMPQRHGPDTFFNF	NBEA	221	Q8NFP9
SMANAGPNTNGSQFF	PPIF	141	P30405
FNPDNPYHQQEGESM	CNMD	256	O75829
QYSHSQGAAEPMGQQ	SS18L1	256	O75177
MFSQQSPPHFGQQAN	NCOA2	1366	Q15596
SIHNFQPPNNSGDGM	ZC3H6	606	P61129
QNFPHGGAMDTHFAN	SGSM1	1011	Q2NKQ1
QFHNEMNFPEGGNSV	ZNF613	171	Q6PF04
DMSTMESGPNNHGNF	PNISR	66	Q8TF01
NEFAQPAFMLDGNNN	PJA2	521	O43164
SSFQEQPHGNITFNM	TGFBR3	581	Q03167
HQGQINDMAFSPDGR	WDR36	621	Q8NI36
ANPRNFNFDNVGNAM	NALCN	1091	Q8IZF0